Six items built around a coordinated GLP-1 + biomarker tracking + glucose monitoring + sleep-cortisol stack. Targets insulin resistance, abdominal adiposity, and the cardiometabolic risk factors that compound with age. Wraps clinical-grade telehealth pharmacology with the tracking layer that makes the protocol legible to your physician.
GLP-1 receptor agonists (Semaglutide, Tirzepatide) are arguably the most consequential metabolic-health pharmacology development of the past decade. The SELECT trial (Lincoff et al., NEJM 2023) showed substantial cardiovascular event reduction. Emerging data on cognitive protection. Real-world weight changes that most diet protocols can't replicate.
The missing piece for most users: data infrastructure to know whether the protocol is actually working at the metabolic-marker level (ApoB, fasting insulin, HbA1c, hsCRP) — and continuous glucose data to learn how YOUR body responds to specific foods during the protocol. This stack wraps the GLP-1 layer (bmiMD telehealth at compounded pricing vs $1,400/mo brand) with the biomarker layer (Mito Health 2x/year), the glucose layer (Ambrosia RIZZ ring, the first non-invasive ring-form-factor CGM), and the foundational supplements that protect muscle mass during weight changes (creatine + magnesium).
We've recommended this stack to buyers who completed initial GLP-1 protocols and wanted to actually track outcomes vs. just lose weight. The biomarker delta visibility transforms the experience.
The stack
GLP-1 Telehealth (Semaglutide / Tirzepatide)
Why it's in this stack: Compounded Semaglutide ($249/mo) and Tirzepatide ($349/mo) via telehealth — same active compounds as Wegovy/Zepbound at 5-7x lower cost than uninsured brand. 60K+ active members, 4.9 star track record, US-licensed physician oversight, 503A patient-specific compounding (compliant pharmacy regulatory framework).
Mito Health Membership
Why it's in this stack: $359/yr for 100+ biomarkers 2x/year. Without comprehensive labs (ApoB, fasting insulin, HbA1c, hsCRP, lipid panel) you cannot tell whether the GLP-1 protocol is actually moving the metabolic markers that matter for cardiovascular risk reduction. Pre-protocol baseline + 6-month re-test is the right cadence.
RIZZ
Why it's in this stack: First ring-form-factor non-invasive CGM in 2026. Continuous glucose-trend tracking without sensor swaps every 14 days. The right add-on to a GLP-1 protocol because seeing your post-meal glucose response in real time accelerates the food-swap learning curve. $399-599 hardware, no subscription.
Weighted Blanket
Why it's in this stack: Cortisol regulation is critical during metabolic protocols — chronic cortisol elevation undermines insulin sensitivity and undermines body-composition outcomes. Weighted blanket triggers parasympathetic activation that drops cortisol overnight. RCT-supported, $200, the most leveraged sub-$300 cortisol intervention on the market.
Creatine HCl Gummies
Why it's in this stack: Muscle-mass preservation is a real concern during GLP-1 weight loss protocols. Creatine is the most-studied supplement for muscle preservation and cognitive maintenance under reduced caloric intake. Gummy format (CON-CRET HCl) hits the compliance constraint that kills monohydrate adherence.
Nordic Magnesium Stack
Why it's in this stack: Multi-form magnesium (glycinate + threonate + citrate) covers sleep, cognitive, and digestive use cases simultaneously. Magnesium deficiency is common during metabolic protocols and affects sleep architecture, glucose tolerance, and muscle function. Nordic clean-label formulation.
Sequence: month 1 baseline labs (Mito Health) + foundational supplements + Mosaic for cortisol/sleep. Month 2-3: start GLP-1 protocol with bmiMD + add Ambrosia RIZZ for glucose pattern recognition. Re-test biomarkers at 6 months to assess delta.